Filter articles using the following links

Advanced Therapies – Virtual

GenSight Biologics Appoints Françoise de Craecker to its Board of Directors

GenSight Biologics Provides 2021 Operations Update in the Context of COVID-19

GenSight Biologics Announces Publication of Results from the REALITY LHON Natural History Study in the Journal Eye

Annual General Meeting 2021

2021 ARVO Annual Meeting, virtual

GenSight Biologics Reports Cash Position as of March 31, 2021 and Provides Operational Update

Mitochondria-Targeted Drug Development Summit, Digital

GenSight Biologics Announces the Filing of its 2020 Universal Registration Document

Annual General Meeting on April 29, 2021